US FDA approves Gamida's blood cancer therapy
17/04/2023 18:07
April 17 (Reuters) - The U.S. Food and Drug Administration has approved Gamida Cell Ltd's GMDA.O blood cancer therapy, Omisirge, the health regulator said on Monday. (Reporting by Pratik Jain in Bengaluru) ((Pratik.Jain@thomsonreuters.com;))
Recent news on Gamida Cell
See all newsBrief: Gamida Cell Appoints Joe Wiley As CEO
Brief: Gamida Cell Says District Court Of Beersheba, Israel Entered Judgment In Restructuring Proceeding
Israeli ADRs up on hopes of de-escalation in Israel-Iran tensions
Brief: Aquestive Therapeutics Strengthens Board Of Directors With Experienced Biotech Executive
Brief: Gamida Cell Ltd Says Received Notice From Nasdaq Notifying Co That It Determined Co’S Ordinary Shares Will Be Delisted From Nasdaq